Petrovax has announced encouraging findings from the Long-CoV-III-21 trial, a randomised, double-blind, placebo-controlled study evaluating the efficacy and safety of…
The latest webinar from EMIS, a leading healthcare technology provider, showcased its Pathway platform—a robust tool designed to improve the…
Sustainability in the 21st century is an essential component of business operations. With regard to environmental stewardship, new regulations in…
Despite their potential to revolutionise medicine, stem cell therapies have long faced scepticism within the pharmaceutical industry. Concerns about the…
On-dose authentication, the practice of integrating traceable markers directly into or onto pharmaceutical products, is yet to be implemented within…
The pharmaceutical industry is undergoing a major transformation, as clinical trials become increasingly data heavy and digital-based. Traditional methods of…
Despite the best efforts of pharmaceutical manufacturers and regulators to improve the security and traceability of drug products, counterfeits continue…
The global clinical trials landscape has transformed significantly over the past five years. The Covid-19 pandemic accelerated the rapid adoption…
Chronic lymphocytic leukaemia is a slow-growing leukaemia characterised by the accumulation of dysfunctional B lymphocytes, primarily affecting older adults. Its…
The latest ICH guideline, Q14, complements Q2(R2) for the validation of analytical procedures. Revision of Q2(R1) into Q2(R2) aligns its…
